NAV on 2019/01/18
|NAV on 2019/01/17
|52 week high on 2018/09/05
|52 week low on 2018/03/26
|Total Expense Ratio on 2018/09/30
|Total Expense Ratio (performance fee) on 2018/09/30
Sanlam Collective Investments
CPI plus 6%(net of fees)
No email address listed.
No website listed.
Anton Botha is a co-founder and co-owner of Imalivest. He spent most of his career as Chief Executive of Genbel and Gensec, building it into a leading South African investment banking group. Before it became a wholly owned subsidiary of Sanlam Ltd in December 2000, Gensec was recognized as one of South Africa’s 40 largest listed companies. Currently Anton serves as a non-executive director on the boards of African Rainbow Minerals Ltd, JSE Ltd, Vukile Property Fund Ltd (Chairman), University of Pretoria, Sanlam Ltd and Sanlam subsidiaries. He is also a past-President of the AHI (Afrikaanse Handelsinstituut) and is actively involved in organised business. Anton holds commerce degrees from the University of Pretoria and Rand Afrikaans University (RAU), a law degree from the University of South Africa and attended an executive management course at Stanford University in the USA.
Johan van Reenen
Johan van Reenen is a co-founder and co-owner of Imalivest. He spent the latter part of his investment career as executive director of Gensec Ltd and managing director of Gensec Asset Management and has a wealth of experience in corporate finance, investment banking and asset management both locally and internationally. Johan currently serves as a non-executive director on the board of MMI Holdings Ltd, Momentum Africa Investment (Pty) Ltd and serves on the Risk, Remuneration and Investment sub committees of the MMI Holdings Board. He is also a director of various privately held companies. In addition, he is a Trustee of the World Wild Life Foundation and a past chairman of the University of the Free State Foundation. Johan holds a BSc (Hons.)(Geochemistry) degree from the University of the Free State and a MBA degree from the University of Stellenbosch.
Imalivest SCI Worldwide Flexible Fund - Sep 18
Over the long term, equity investments deliver superior returns to investors. For this reason, our portfolio will be fully invested in equities most of the time, unless we consider equity valuations to be expensive or we need to contain risk.
When evaluating equities, we tend to follow a value investment approach with a preference for high quality companies with the potential to generate stable, consistent returns. The importance of identifying and investing in these companies is to harness the compounding effect on shareholder return.
We continue to believe that the wider TECHNOLOGY sector offers an attractive investment opportunity and therefore our portfolio is still heavily invested in these stocks for the following reasons: -All sectors and companies rely on technology to improve their quality, productivity and/or profitability. -In a highly competitive global economy, companies need to spend on IT to build and protect their market shares. -Capital projects have large technology components. -Ever increasing global data traffic presents a growth opportunity for device makers, semi-conductors and networking companies.
True to our philosophy, we only invest in companies that we regard as quality businesses and that offer value and therefore high growth technology companies won’t normally be found in our portfolios.
The US CONSUMER has capacity to spend due to low fuel costs and low borrowing rates. We anticipate spending to remain strong fuelled further by the strong job market (unemployment is at its lowest) lifting consumer income expectations, causing consumers to save less (currently the personal savings rate in the US is still very high) and spend more on discretionary items. We focus on gaining exposure to this theme via consumer finance stocks like American Express and Synchrony Financial.
EXPRESS SCRIPTS has been one of our bigger positions for quite some time. Earlier this year Cigna announced their intention to buy out the company. As the buy-out became more and more definite during the course of the year Express Scripts’ share price gradually closed the discount to the price offered by Cigna. We decided to exit the position and at the end of quarter 3 we have already halved our position with the remaining shares to be sold in the beginning of quarter 4.
The Imalivest Sanlam Collective Investments Worldwide Flexible Fund is a worldwide flexible portfolio that aims to provide investors with reasonably high long term total returns. The portfolio may invest in financially sound global and local equity securities, government -, corporate- and inflation linked bonds, debentures, non-equity securities, property shares, property related securities, preference shares, money market instruments and assets in liquid form. The portfolio may also invest in participatory interests and other forms of participation in portfolios of collective investment schemes or other similar schemes operated in territories with a regulatory environment which is to the satisfaction of the manager and trustee of a sufficient standard to provide investor protection at least equivalent to that in South Africa and which is consistent with the portfolio's primary objective. The Manager may make active use of derivatives to reduce the risk that a general decline in the value of equity, property and bond markets may have on the value of the portfolio. The manager shall have the maximum flexibility to vary assets between the various markets, asset classes and countries to reflect the changing economic and market conditions.